TherapeuticsMD
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2008-01-01
- Employees
- 1
- Market Cap
- $22.1M
- Introduction
TherapeuticsMD, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of products for women. The firm's technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. It also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.
Annoveraâ„¢ Drug-Drug Interaction Study
- Conditions
- WomenContraception
- Interventions
- First Posted Date
- 2020-02-28
- Last Posted Date
- 2021-01-29
- Lead Sponsor
- TherapeuticsMD
- Target Recruit Count
- 67
- Registration Number
- NCT04290390
- Locations
- 🇨🇦
Syneos Health, Quebec City, Quebec, Canada
The Effects of Annoveraâ„¢ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol
- Conditions
- Contraception
- Interventions
- Drug: Segesterone Acetate and Ethinyl EstradiolOther: Tampon
- First Posted Date
- 2020-02-17
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- TherapeuticsMD
- Target Recruit Count
- 21
- Registration Number
- NCT04272008
- Locations
- 🇨🇦
Syneos Health, Québec City, Quebec, Canada
🇺🇸University of Pennsylvania Women's Health Clinical Research Center, Philadelphia, Pennsylvania, United States
TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy
- Conditions
- MenopauseDyspareuniaVulvovaginal AtrophyPainful Intercourse
- Interventions
- Drug: placeboDrug: Estradiol
- First Posted Date
- 2015-05-20
- Last Posted Date
- 2015-12-14
- Lead Sponsor
- TherapeuticsMD
- Target Recruit Count
- 50
- Registration Number
- NCT02449902
- Locations
- 🇺🇸
Avail Clinical Research, DeLand, Florida, United States
Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women
- Conditions
- DyspareuniaVulvovaginal AtrophyMenopausePainful Intercourse
- Interventions
- Drug: EstradiolDrug: Placebo
- First Posted Date
- 2014-10-01
- Last Posted Date
- 2017-05-25
- Lead Sponsor
- TherapeuticsMD
- Target Recruit Count
- 764
- Registration Number
- NCT02253173
- Locations
- 🇺🇸
Women's Clinic of Lincoln, Lincoln, Nebraska, United States
🇺🇸Chattanooga Medical Research, Chattanooga, Tennessee, United States
🇺🇸Medical Affiliated Research Center, Huntsville, Alabama, United States
A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea
- First Posted Date
- 2013-12-24
- Last Posted Date
- 2018-05-08
- Lead Sponsor
- TherapeuticsMD
- Target Recruit Count
- 6
- Registration Number
- NCT02019589
- Locations
- 🇺🇸
The Woman's Hospital of Texas Clinical Research Center, Houston, Texas, United States
🇺🇸Precision Clinical Trials/Arizona Wellness Center for Women, Phoenix, Arizona, United States
🇺🇸Precision Trials/New Horizons Women's Care, Chandler, Arizona, United States
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
- First Posted Date
- 2013-09-16
- Last Posted Date
- 2019-05-06
- Lead Sponsor
- TherapeuticsMD
- Target Recruit Count
- 1845
- Registration Number
- NCT01942668
- Locations
- 🇺🇸
Accelovance, Melbourne, Florida, United States
🇺🇸Clinical Research of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Radiant Research (Chicago), Chicago, Illinois, United States